Effectiveness of nirmatrelvir/ritonavir and molnupiravir on post-COVID-19 outcomes among outpatients: a target trial emulation investigation

DOI record: { "DOI": "10.1080/22221751.2025.2469648", "ISSN": [ "2222-1751" ], "URL": "http://dx.doi.org/10.1080/22221751.2025.2469648", "alternative-id": [ "10.1080/22221751.2025.2469648" ], "assertion": [ { "label": "Peer Review Statement", "name": "peerreview_statement", "order": 1, "value": "The publishing and review policy for this title is described in its Aims & Scope." }, { "URL": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=temi20", "label": "Aim & Scope", "name": "aims_and_scope_url", "order": 2, "value": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=temi20" }, { "group": { "label": "Publication History", "name": "publication_history" }, "label": "Published", "name": "published", "order": 3, "value": "2025-02-18" } ], "author": [ { "affiliation": [ { "name": "School of Public Health and Primary Care, The Chinese University of Hong Kong", "place": [ "Hong Kong" ] } ], "family": "Wei", "given": "Yuchen", "sequence": "first", "suffix": "PhD" }, { "affiliation": [ { "name": "Harvard T.H. Chan School of Public Health", "place": [ "Boston, Massachusetts, United States" ] } ], "family": "Boyer", "given": "Christopher", "sequence": "additional", "suffix": "PhD" }, { "affiliation": [ { "name": "Harvard T.H. Chan School of Public Health", "place": [ "Boston, Massachusetts, United States" ] } ], "family": "Jia", "given": "Katherine Min", "sequence": "additional", "suffix": "MSc" }, { "affiliation": [ { "name": "School of Public Health and Primary Care, The Chinese University of Hong Kong", "place": [ "Hong Kong" ] } ], "family": "Lin", "given": "Guozhang", "sequence": "additional", "suffix": "MSc" }, { "affiliation": [ { "name": "School of Public Health and Primary Care, The Chinese University of Hong Kong", "place": [ "Hong Kong" ] } ], "family": "Wang", "given": "Huwen", "sequence": "additional", "suffix": "MPhil" }, { "affiliation": [ { "name": "School of Public Health and Primary Care, The Chinese University of Hong Kong", "place": [ "Hong Kong" ] } ], "family": "Li", "given": "Conglu", "sequence": "additional", "suffix": "MSc" }, { "affiliation": [ { "name": "School of Public Health and Primary Care, The Chinese University of Hong Kong", "place": [ "Hong Kong" ] } ], "family": "Hung", "given": "Chi Tim", "sequence": "additional", "suffix": "MBBS" }, { "affiliation": [ { "name": "School of Public Health and Primary Care, The Chinese University of Hong Kong", "place": [ "Hong Kong" ] } ], "family": "Jiang", "given": "Xiaoting", "sequence": "additional", "suffix": "MSc" }, { "affiliation": [ { "name": "School of Public Health and Primary Care, The Chinese University of Hong Kong", "place": [ "Hong Kong" ] } ], "family": "Kwan Yam", "given": "Carrie Ho", "sequence": "additional", "suffix": "PhD" }, { "affiliation": [ { "name": "School of Public Health and Primary Care, The Chinese University of Hong Kong", "place": [ "Hong Kong" ] } ], "family": "Chow", "given": "Tsz Yu", "sequence": "additional", "suffix": "BSc" }, { "affiliation": [ { "name": "The University of Hong Kong", "place": [ "Hong Kong" ] } ], "family": "Wang", "given": "Yawen", "sequence": "additional", "suffix": "PhD" }, { "affiliation": [ { "name": "School of Public Health and Primary Care, The Chinese University of Hong Kong", "place": [ "Hong Kong" ] }, { "name": "School of Public Health, Tianjin Medical University", "place": [ "Tianjin, China" ] } ], "family": "Zhao", "given": "Shi", "sequence": "additional", "suffix": "PhD" }, { "affiliation": [ { "name": "School of Public Health and Primary Care, The Chinese University of Hong Kong", "place": [ "Hong Kong" ] } ], "family": "Guo", "given": "Zihao", "sequence": "additional", "suffix": "MSc" }, { "affiliation": [ { "name": "School of Public Health and Primary Care, The Chinese University of Hong Kong", "place": [ "Hong Kong" ] } ], "family": "Li", "given": "Kehang", "sequence": "additional", "suffix": "MSc" }, { "affiliation": [ { "name": "The Chinese University of Hong Kong", "place": [ "Hong Kong" ] } ], "family": "Yang", "given": "Aimin", "sequence": "additional", "suffix": "PhD" }, { "affiliation": [ { "name": "Chinese University of Hong Kong", "place": [ "Hong Kong" ] } ], "family": "Pun Mok", "given": "Chris Ka", "sequence": "additional", "suffix": "PhD" }, { "affiliation": [ { "name": "S.H. Ho Research Centre for Infectious Diseases, Chinese University of Hong Kong", "place": [ "Hong Kong" ] } ], "family": "Hui", "given": "David SC", "sequence": "additional", "suffix": "MBBS" }, { "affiliation": [ { "name": "School of Public Health and Primary Care, The Chinese University of Hong Kong", "place": [ "Hong Kong" ] } ], "family": "Chong", "given": "Ka Chun", "sequence": "additional", "suffix": "PhD" }, { "affiliation": [ { "name": "School of Public Health and Primary Care, The Chinese University of Hong Kong", "place": [ "Hong Kong" ] } ], "family": "Yeoh", "given": "Eng Kiong", "sequence": "additional", "suffix": "MBBS" } ], "container-title": "Emerging Microbes & Infections", "container-title-short": "Emerging Microbes & Infections", "content-domain": { "crossmark-restriction": true, "domain": [ "www.tandfonline.com" ] }, "created": { "date-parts": [ [ 2025, 2, 18 ] ], "date-time": "2025-02-18T13:19:16Z", "timestamp": 1739884756000 }, "deposited": { "date-parts": [ [ 2025, 2, 18 ] ], "date-time": "2025-02-18T13:19:33Z", "timestamp": 1739884773000 }, "funder": [ { "DOI": "10.13039/501100005847", "award": [ "COVID190105, COVID19F03, INF-CUHK-1, COVID1903003" ], "doi-asserted-by": "crossref", "id": [ { "asserted-by": "crossref", "id": "10.13039/501100005847", "id-type": "DOI" } ], "name": "Health and Medical Research Fund" }, { "award": [ "C6036-21GF" ], "name": "RGC Collaborative Research Fund" }, { "award": [ "T11-705/21-N" ], "name": "RGC theme-based research schemes" } ], "indexed": { "date-parts": [ [ 2025, 2, 19 ] ], "date-time": "2025-02-19T05:14:51Z", "timestamp": 1739942091801, "version": "3.37.3" }, "is-referenced-by-count": 0, "issued": { "date-parts": [ [ 2025, 2, 18 ] ] }, "language": "en", "license": [ { "URL": "http://creativecommons.org/licenses/by/4.0/", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 2, 18 ] ], "date-time": "2025-02-18T00:00:00Z", "timestamp": 1739836800000 } } ], "link": [ { "URL": "https://www.tandfonline.com/doi/pdf/10.1080/22221751.2025.2469648", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "301", "original-title": [], "prefix": "10.1080", "published": { "date-parts": [ [ 2025, 2, 18 ] ] }, "published-online": { "date-parts": [ [ 2025, 2, 18 ] ] }, "publisher": "Informa UK Limited", "reference": [ { "key": "e_1_3_2_2_1", "unstructured": "Fact sheet for healthcare providers: emergency use authorization for Paxlovid™. (www.fda.gov/media/155050/download)" }, { "key": "e_1_3_2_3_1", "unstructured": "Fact sheet for healthcare providers: emergency use authorization for Lagevrio™ (molnupiravir) capsules. (www.fda.gov/media/155054/download)" }, { "DOI": "10.1056/NEJMoa2118542", "doi-asserted-by": "crossref", "key": "e_1_3_2_4_1", "unstructured": "Hammond J Leister-Tebbe H Gardner A Abreu P Bao W Wisemandle W Baniecki M Hendrick VM Damle B Simón-Campos A Pypstra R Rusnak JM; EPIC-HR Investigators. Oral Nirmatrelvir for High-Risk Nonhospitalized Adults with Covid-19. N Engl J Med. 2022 Apr 14;386(15):1397-1408." }, { "DOI": "10.1056/NEJMoa2204919", "doi-asserted-by": "crossref", "key": "e_1_3_2_5_1", "unstructured": "Arbel R Wolff Sagy Y Hoshen M et al. Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge. N Engl J Med 2022; 387(9): 790-8." }, { "DOI": "10.1016/S1473-3099(22)00507-2", "doi-asserted-by": "crossref", "key": "e_1_3_2_6_1", "unstructured": "Wong CKH Au ICH Lau KTK Lau EHY Cowling BJ Leung GM. Real-world effectiveness of early molnupiravir or nirmatrelvir-ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong's omicron BA.2 wave: a retrospective cohort study. Lancet Infect Dis 2022; 22(12): 1681-93" }, { "DOI": "10.1056/NEJMoa2309003", "doi-asserted-by": "crossref", "key": "e_1_3_2_7_1", "unstructured": "Hammond J Fountaine RJ Yunis C Fleishaker D Almas M Bao W Wisemandle W Rusnak JM. Nirmatrelvir for vaccinated or unvaccinated adult outpatients with Covid-19. N Engl J Med 2024;360:1186-1195." }, { "DOI": "10.1001/jamainternmed.2023.0743", "doi-asserted-by": "crossref", "key": "e_1_3_2_8_1", "unstructured": "Xie Y Choi T Al-Aly Z. Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition. JAMA Intern Med 2023; 183(6): 554-64." }, { "DOI": "10.1016/S1473-3099(24)00217-2", "doi-asserted-by": "crossref", "key": "e_1_3_2_9_1", "unstructured": "Wang H Wei Y Hung CT Lin G Jiang X Li C Jia KM Yam CHK Chow TY Ho JY Wang Y Zhao S Guo Z Li K Yang A Mok CKP Hui DSC Yeoh EK Chong KC. Association of nirmatrelvir-ritonavir with post-acute sequelae and mortality in patients admitted to hospital with COVID-19: a retrospective cohort study. Lancet Infect Dis. 2024 May 3:S1473-3099(24)00217-2." }, { "DOI": "10.7326/M23-1394", "doi-asserted-by": "crossref", "key": "e_1_3_2_10_1", "unstructured": "Ioannou GN Berry K Rajeevan N et al. Effectiveness of Nirmatrelvir-Ritonavir Against the Development of Post-COVID-19 Conditions Among U.S. Veterans : A Target Trial Emulation. Ann Intern Med 2023; 176(11): 1486-97." }, { "DOI": "10.1002/jmv.29333", "doi-asserted-by": "crossref", "key": "e_1_3_2_11_1", "unstructured": "Durstenfeld MS Peluso MJ Lin F et al. Association of nirmatrelvir for acute SARS-CoV-2 infection with subsequent Long COVID symptoms in an observational cohort study. J Med Virol 2024; 96(1): e29333." }, { "DOI": "10.7326/M22-3565", "doi-asserted-by": "crossref", "key": "e_1_3_2_12_1", "unstructured": "Bajema KL Berry K Streja E Rajeevan N Li Y Mutalik P Yan L Cunningham F Hynes DM Rowneki M Bohnert A Boyko EJ Iwashyna TJ Maciejewski ML Osborne TF Viglianti EM Aslan M Huang GD Ioannou GN. Effectiveness of COVID-19 Treatment With Nirmatrelvir-Ritonavir or Molnupiravir Among U.S. Veterans: Target Trial Emulation Studies With One-Month and Six-Month Outcomes. Ann Intern Med. 2023 Jun;176(6):807-816." }, { "DOI": "10.1001/jamainternmed.2023.5099", "doi-asserted-by": "crossref", "key": "e_1_3_2_13_1", "unstructured": "Fung KW Baye F Baik SH McDonald CJ. Nirmatrelvir and Molnupiravir and Post-COVID-19 Condition in Older Patients. JAMA Intern Med. 2023 Dec 1;183(12):1404-1406." }, { "DOI": "10.1016/j.jinf.2023.03.016", "doi-asserted-by": "crossref", "key": "e_1_3_2_14_1", "unstructured": "Hsu WH Shiau BW Tsai YW Wu JY Liu TH Chuang MH Lai CC. The effect of molnupiravir on post-acute outcome of COVID-19 survivors. J Infect. 2023 Oct;87(4):339-343." }, { "DOI": "10.1136/bmj-2022-074572", "doi-asserted-by": "crossref", "key": "e_1_3_2_15_1", "unstructured": "Xie Y Choi T Al-Aly Z. Molnupiravir and risk of post-acute sequelae of covid-19: cohort study. BMJ. 2023 Apr 25;381:e074572." }, { "DOI": "10.1001/jamanetworkopen.2022.54777", "doi-asserted-by": "crossref", "key": "e_1_3_2_16_1", "unstructured": "Wei Y Jia KM Zhao S Hung CT Mok CKP Poon PKM Man Leung EY Wang MH Yam CHK Chow TY Guo Z Yeoh EK Chong KC. Estimation of Vaccine Effectiveness of CoronaVac and BNT162b2 Against Severe Outcomes Over Time Among Patients With SARS-CoV-2 Omicron. JAMA Netw Open. 2023 Feb 1;6(2):e2254777." }, { "key": "e_1_3_2_17_1", "unstructured": "Lin G Wei Y Wang H Boyer C Jia KM Hung CT Jiang X Li C Yam CHK Chow TY Wang Y Zhao S Guo Z Li K Yang A Mok CKP Hui DSC Chong KC Yeoh EK. Association of nirmatrelvir-ritonavir with post-acute sequelae and mortality among patients who are immunocompromised with COVID-19 in Hong Kong: a retrospective cohort study. Lancet Rheumatol. 2024 Nov 8:S2665-9913(24)00224-8." }, { "DOI": "10.1016/j.eclinm.2023.102000", "doi-asserted-by": "crossref", "key": "e_1_3_2_18_1", "unstructured": "Lam ICH Wong CKH Zhang R et al. Long-term post-acute sequelae of COVID-19 infection: a retrospective multi-database cohort study in Hong Kong and the UK. EClinicalMedicine 2023; 60: 102000." }, { "DOI": "10.1007/s10787-023-01204-1", "doi-asserted-by": "crossref", "key": "e_1_3_2_19_1", "unstructured": "Sebők S Gyires K. Long COVID and possible preventive options. Inflammopharmacology 2023; 31(6): 2807-17." }, { "DOI": "10.1016/j.antiviral.2022.105252", "doi-asserted-by": "crossref", "key": "e_1_3_2_20_1", "unstructured": "Vangeel L Chiu W De Jonghe S Maes P Slechten B Raymenants J André E Leyssen P Neyts J Jochmans D. Remdesivir Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern. Antiviral Res. 2022 Feb;198:105252." }, { "DOI": "10.1038/s41390-022-02111-x", "doi-asserted-by": "crossref", "key": "e_1_3_2_21_1", "unstructured": "Kostev K Smith L Koyanagi A Konrad M Jacob L. Post-COVID-19 conditions in children and adolescents diagnosed with COVID-19. Pediatr Res. 2024 Jan;95(1):182-187." }, { "DOI": "10.1002/jmv.28648", "doi-asserted-by": "crossref", "key": "e_1_3_2_22_1", "unstructured": "Guo Z Zhao S Mok CKP So RTY Yam CHK Chow TY Chan TCP Wei Y Jia KM Wang MH Chong KC Yeoh EK. Comparing the incubation period serial interval and infectiousness profile between SARS-CoV-2 Omicron and Delta variants. J Med Virol. 2023 Mar;95(3):e28648." }, { "key": "e_1_3_2_23_1", "unstructured": "National Institutes of Health. Therapeutic Management of Nonhospitalized Adults With COVID-19. Updated 20 April 2023. Accessed at www.covid19treatmentguidelines.nih.gov/management/clinical-management-of-adults/nonhospitalized-adults-therapeuticmanagement on 21 March 2023." }, { "DOI": "10.1080/22221751.2024.2421397", "doi-asserted-by": "crossref", "key": "e_1_3_2_24_1", "unstructured": "Wang H Wei Y Lin G Boyer C Jia KM Hung CT Jiang X Li C Yam CHK Chow TY Wang Y Zhao S Guo Z Li K Yang A Mok CKP Hui DSC Chong KC Yeoh EK. COVID-19 vaccination modified the effect of nirmatrelvir-ritonavir on post-acute mortality and rehospitalization: a retrospective cohort study. Emerg Microbes Infect. 2024 Dec;13(1):2421397." }, { "DOI": "10.1016/j.jclinepi.2023.08.003", "doi-asserted-by": "crossref", "key": "e_1_3_2_25_1", "unstructured": "Zuo H Yu L Campbell SM Yamamoto SS Yuan Y. The implementation of target trial emulation for causal inference: a scoping review. J Clin Epidemiol. 2023 Oct;162:29-37." } ], "reference-count": 24, "references-count": 24, "relation": {}, "resource": { "primary": { "URL": "https://www.tandfonline.com/doi/full/10.1080/22221751.2025.2469648" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Effectiveness of nirmatrelvir/ritonavir and molnupiravir on post-COVID-19 outcomes among outpatients: a target trial emulation investigation", "type": "journal-article", "update-policy": "https://doi.org/10.1080/tandf_crossmark_01" }